← Eichor
Study identifier: NCT05429138 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma

Condition: Melanoma  ·  Sponsor: Assistance Publique Hopitaux De Marseille

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

Prospective multicentric study including women aged 18 to 37 and men aged 18 to 45 during their visit to centers for the study and storage of human sperm and eggs (CECOS). Subjects will be included before adjuvant treatment initiation (T0) and immediately after treatment (approximately 1 year after initiation, T1), and, in late post treatment (1 year after treatment cessation, T2). Expected results: This study will evaluate the evolution of AMH, AFC, and semen parameters in our cohort of melanoma patients treated with anti-PD-1 and targeted therapy in an adjuvant and neoadjuvantsettings.

This description comes directly from the study's public registry record.

Talk to the study team

Nausicaa Malissen, MD, PhD  ·  0491384215  ·  nausicaa.malissen@ap-hm.fr

DRSMR AP-HM  ·  promotion.interne@ap-hm.fr

Always discuss trial participation with your own doctor first.

Locations (12)

CHU de BordeauxBordeaux, FranceRecruiting
AP-HMMarseille, FranceRecruiting
Hôpital Saint-JosephMarseille, FranceRecruiting
CHU MontpellierMontpellier, FranceRecruiting
CHU de NantesNantes, FranceRecruiting
CHU NICE L'archetNice, FranceRecruiting
CHRU de NîmesNîmes, FranceRecruiting
APHP- Ambroise ParéParis, FranceRecruiting
APHP-CochinParis, FranceRecruiting
APHP-Saint LouisParis, FranceRecruiting
Oncôpole de ToulouseToulouse, FranceRecruiting
Institut Gustave RoussyVillejuif, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05429138